NCT02017808View on ClinicalTrials.gov

Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Multiple Sclerosis
Trial Locations (1)

14203

Buffalo Neuroimaging Analysis Center, Buffalo

All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

University at Buffalo

OTHER

NCT02017808 - Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months | Biotech Hunter | Biotech Hunter